Navigation Links
Hepatitis C Occurs Even After Liver Transplantation

The serum viral levels fall after the removal of a diseased liver from a Hepatitis C (HCV) patient. Virus levels are found to return even after a healthy liver transplant, which can even go beyond pre-transplant levels, // according to a new research results published in the American Association for the Study of Liver Diseases’ (AASLD) Liver Transplantation journal. The chief reason for most liver transplantations is Hepatitis C.

As many as six liver transplant patients who had undergone cadaveric liver transplants as result of HCV infection were studied by the team of researchers. The levels of the HCV RNA were measured for changes with blood tests before, during and after the transplant operation utilizing the reverse transcription polymerase chain reaction assay, and linear regression was used to analyze the results.

It was seen that the HCV RNA levels fell in the case of most patients during the course of the transplantation operation, which rose subsequently afterwards, until a level which is above the pre-transplantation level is attained, in some cases growing by 100% every 2 days.

In the case of three patients there was a plateauing of the level before rising. As much as 4% of the viral production is from non-hepatic sources, while the liver accounts for the balance 96%, which goes to prove that the primary viral replication takes place in the liver. The virion half-life seen in this study is very much higher than what has been observed in previous studies, even though the rise and fall of the viremia appears to be the same.
'"/>




Page: 1

Related medicine news :

1. Vitamin B for Hepatitis
2. Hepatitis G May Boost HIV Survival
3. Cure for Hepatitis B
4. Hepatitis E virus made impotent
5. Sharing injection equipment spreads Hepatitis C
6. Lymphomas Link to Hepatitis C
7. Hepatitis shots is promising
8. Need for Hepatitis Booster Questioned
9. Good News for HIV Patients Also Suffering From Hepatitis C Virus
10. The Link Between Hepatitis B Vaccine And Multiple Sclerosis Questioned
11. The Effectiveness Of Hepatitis B Vaccine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... Apple Rehab Shelton Lakes , which specializes in the ... facility as part of a disaster drill on October 3rd. , Apple Rehab participated ... Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid Plan ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: